The Latest Breaking News from Elizabeth Prelogar

U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.

Justices appear skeptical of arguments against mifepristone as pharmaceutical industry considers case existential threat

Both conservative and liberal justices questioned whether the plaintiffs could show direct injury merely because they object to abortion.

Live commentary on the Supreme Court oral argument in FDA v. Alliance for Hippocratic Medicine

Two cases on tap Monday pit Texas and Florida laws against First Amendment rights of large internet companies.

I'm delighted to pass along this item from Prof. Thomas Merrill (Columbia), whom readers might remember as a guest-blogger from a couple of years ago, and who is the author of The Chevron Doctrine: Its Rise, and Fall, and the Future of the Administrative State (2022): Last week, the Supreme…

The justices seem inclined to revise or ditch a 1984 precedent that requires deference to executive agencies' statutory interpretations.

The Supreme Court heard arguments in two cases that could remove the deference given to the executive branch in interpreting law.

The Supreme Court seems inclined to uphold a tax on foreign income while leaving broader questions about a never-enacted tax on wealth for another day

Most of the Supreme Court expressed skepticism Tuesday about a challenge to the constitutionality of a 2017 tax provision.

Misdemeanants don’t fall within the “not law-abiding” category.